CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Succeeder Technology Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Succeeder Technology Inc
No. 19, Baili Street, Daxing District
Phone: +86 1053855568p:+86 1053855568 BEIJING, BEJ  102600  China Ticker: 688338688338
Business Summary
Beijing Succeeder Technology Inc is a China-based company mainly engaged in the research and development, production and sales of testing instruments, reagents and consumables in the field of thrombosis and hemostasis in vitro diagnosis. The Company provides medical institutions with automated detection equipment for blood coagulation, blood rheology, hematocrit, platelet aggregation, and supporting reagents and consumables. Its products include testing instruments, reagents and consumables, such as automatic coagulation testers, coagulation quality control kits, Newtonian fluid quality controls, reaction cups and SAW blood rheology special cleaning. The Company operates its businesses within the domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus
2835 In vitro and in vivo diagnostic substances
3826 Laboratory analytical instruments
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ShimingWu 65 11/1/2020 1/1/2003
Finance Director, Director GuoLi 45
General Manager, Director HaiWang 50
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 296 (As of 12/31/2023)
Outstanding Shares: 106,142,400 (As of 9/30/2024)
Shareholders: 6,097
Stock Exchange: SHA
Fax Number: +86 1053855570


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024